Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abbas H Azandaryani

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Biotechnology|May 1, 2019
Recent Insights into Effective Nanomaterials and Biomacromolecules Conjugation in Advanced Drug TargetingAbbas H Azandaryani, Soheila Kashanian, Tahereh Jamshidnejad-Tosaramandani
Current Pharmaceutical Biotechnology|November 16, 2019
New Folate-Modified Human Serum Albumin Conjugated to Cationic Lipid Carriers for Dual Targeting of Mitoxantrone against Breast CancerAbbas A Ridha, Soheila Kashanian, Abbas H Azandaryani, et al.
Chemistry and Physics of Lipids|April 11, 2014
Drug targeting using solid lipid nanoparticlesElham Rostami, Soheila Kashanian, Abbas H Azandaryani, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Biotechnology|May 1, 2019
Recent Insights into Effective Nanomaterials and Biomacromolecules Conjugation in Advanced Drug TargetingAbbas H Azandaryani, Soheila Kashanian, Tahereh Jamshidnejad-Tosaramandani
Current Pharmaceutical Biotechnology|November 16, 2019
New Folate-Modified Human Serum Albumin Conjugated to Cationic Lipid Carriers for Dual Targeting of Mitoxantrone against Breast CancerAbbas A Ridha, Soheila Kashanian, Abbas H Azandaryani, et al.
Chemistry and Physics of Lipids|April 11, 2014
Drug targeting using solid lipid nanoparticlesElham Rostami, Soheila Kashanian, Abbas H Azandaryani, et al.
Pageof 1